Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by eric_julien
Group name EquipeEJ
Item Type Journal Article
Title High-resolution live-cell imaging reveals novel cyclin A2 degradation foci involving autophagy
Creator Loukil et al.
Author Abdelhalim Loukil
Author Manuela Zonca
Author Cosette Rebouissou
Author Véronique Baldin
Author Olivier Coux
Author Martine Biard-Piechaczyk
Author Jean-Marie Blanchard
Author Marion Peter
Abstract Cyclin A2 is a key player in the regulation of the cell cycle. Its degradation in mid-mitosis relies on the ubiquitin-proteasome system (UPS). Using high-resolution microscopic imaging, we find that cyclin A2 persists beyond metaphase. Indeed, we identify a novel cyclin-A2-containing compartment that forms dynamic foci. Förster (or fluorescence) resonance energy transfer (FRET) and fluorescence lifetime imaging microscopy (FLIM) analyses show that cyclin A2 ubiquitylation takes place predominantly in these foci before spreading throughout the cell. Moreover, inhibition of autophagy in proliferating cells induces the stabilisation of a subset of cyclin A2, whereas induction of autophagy accelerates the degradation of cyclin A2, thus showing that autophagy is a novel regulator of cyclin A2 degradation.
Publication Journal of Cell Science
Volume 127
Issue Pt 10
Pages 2145-2150
Date May 15, 2014
Journal Abbr J. Cell. Sci.
Language eng
DOI 10.1242/jcs.139188
ISSN 1477-9137
Library Catalog PubMed
Extra PMID: 24634511
Tags Autophagy, Cell Communication, Cyclin A2, FLIM, Fluorescence Resonance Energy Transfer, FRET, Humans, MCF-7 Cells, Microscopy, Fluorescence, original, Proteasome Endopeptidase Complex, Ubiquitin, Ubiquitin-proteasome system
Date Added 2019/05/28 - 13:52:53
Date Modified 2019/05/28 - 13:58:44
Notes and Attachments PubMed entry (Attachment)
Texte intégral (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés